IMP-45-producing multidrug-resistant Pseudomonas aeruginosa of canine origin

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 9, 2014, Pages 2579-2581

  Wang, Yang ^a   Wang, Xin ^a   Schwarz, Stefan ^b   Zhang, Rongmin ^a   Lei, Lei ^a   Liu, Xiaoyu ^a   Lin, Degui ^a   Shen, Jianzhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Carbapenemases; Integrons; Pet animals; Reservoirs

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; VANCOMYCIN; BACTERIAL DNA; BETA LACTAMASE;

ACINETOBACTER; BACTERIAL GENE; BACTERIUM ISOLATE; BLA IMP 45 GENE; BROTH DILUTION; DNA FLANKING REGION; DOG; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; GERMANY; HUMAN; INTEGRON; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PSEUDOMONAS AERUGINOSA; SOUTHERN BLOTTING; TRANSPOSON; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GENE ORDER; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PSEUDOMONAS INFECTION; SECRETION (PROCESS); VETERINARY;

ANIMALS; BETA-LACTAMASES; CARRIER STATE; DNA, BACTERIAL; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE ORDER; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84905985516     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku133     Document Type: Letter

References (10)

1. EUCAST. Clinical Breakpoint Tables (v 3.1). http://www.eucast.org/ clinical_breakpoints/ (4 April 2014, date last accessed).
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.
3. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
4. Valencia R, Arroyo LA, Conde M et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 2009; 30: 257-63.
5. Urban C, Mariano N, Rahal JJ et al. Polymyxin B-resistant Acinetobacter baumannii clinical isolate susceptible to recombinant BPI21 and cecropin P1. Antimicrob Agents Chemother 2001; 45: 994-5.
6. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006; 55: 1619-29.
7. Higgins PG, Dammhayn C, Hackel M et al. Global spread of carbapenemresistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 233-8.
8. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010; 35: 305.
9. Adams-Haduch JM, Onuoha EO, Bogdanovich T et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 2011; 49: 3849-54.
10. Schleicher X, Higgins PG, Wisplinghoff H et al. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009). Clin Microbiol Infect 2013; 19: 737-42.